Pregnancy and Breast Cancer ~ Antonio Giordano, M.D., Ph.D.

Pregnancy after getting diagnosed with breast cancer is possible, but one must be aware of treatments that could undermine fertility. Becoming a mother after a cancer diagnosis, especially breast cancer, is a major concern for young women as in fact treatments like chemotherapy may impair fertility or reproductive capacity. Even though current guidelines do not … Continue reading Pregnancy and Breast Cancer ~ Antonio Giordano, M.D., Ph.D.

Targeting Cervical Cancer Stem Cells to Improve Outcomes

 The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments. Therapeutic targeting of CCSCs has the potential to reduce resistance to conventional therapies but also limit the occurrence of distant metastasis and relapse. Precision medicine … Continue reading Targeting Cervical Cancer Stem Cells to Improve Outcomes

“Healthcare: Social Inequalities affect care and mortality.” ~ by Dr. Antonio Giordano

Weak social groups are diagnosed with more cancers of the digestive system, whereas colorectal cases are more often found in the upper-middle-income social classes. How much does social inequality still affect the evolution of a disease? Evaluating the extent of this impact on the health system would provide us with a complete picture of the … Continue reading “Healthcare: Social Inequalities affect care and mortality.” ~ by Dr. Antonio Giordano

National Doctor’s Day, 30th March 2022 – Dr. Antonio Giordano (SHRO)

Dr. Antonio Giordano with Professors and Researchers at Sbarro Institute (SHRO) at Temple University, Philadelphia In the United States, 30th March is celebrated as National Doctor's Day. In historical terms, on 30th March 1933 wife of Dr. Charles B. Almond, Eudora Brown Almond, set aside a date to honor the contributions of physicians; on that … Continue reading National Doctor’s Day, 30th March 2022 – Dr. Antonio Giordano (SHRO)

‘Early Detection of Cancer’ hope for the underprivileged – Dr. Antonio Giordano

Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) at Temple University's College of Science and Technology, leads a team of researchers and scientists to investigate methods to identify different varieties of cancers at the early stage. Although most people are scared of the word ‘Cancer’ in diseases, as it is well … Continue reading ‘Early Detection of Cancer’ hope for the underprivileged – Dr. Antonio Giordano

Dr Antonio Giordano of Sbarro Health Research Organization: 5 Things Everyone Needs To Know About Cancer

An Interview With Savio P. Clemente Cancer is a treatable disease if caught early. For example, most ovarian cancers are detected at late stage (Stage III or higher) and by this time, the cancer is less sensitive to many of the therapies we have available for this disease. The same for breast cancer. Much work … Continue reading Dr Antonio Giordano of Sbarro Health Research Organization: 5 Things Everyone Needs To Know About Cancer

Post-Covid Effects: The Invisible Enemy of Memory and Cognitive Skills

According to recent studies, all those recovered showed up to 9 months later a significant reduction in the ability to apply themselves to a challenging task. Post Covid Effects: Analysis by Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) based on recent research studies by several institutions. Sars-Cov2, despite being a … Continue reading Post-Covid Effects: The Invisible Enemy of Memory and Cognitive Skills

“Omicron: Be Alarmed, not panic! Here is the new management of the pandemic” – Dr. Antonio Giordano

Scientists are examining a new coexistence with the virus: isolation of only positives and changes to quarantines limited to close positive contacts 'Omicron and how it's managed at present' a viewpoint shared by Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) http://www.shro.org The Omicron variant with its high transmissibility rates is … Continue reading “Omicron: Be Alarmed, not panic! Here is the new management of the pandemic” – Dr. Antonio Giordano

Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow

There is no doubt that the use of recently approved drugs to “boost” the immune response to cancer cells represents a novelty that has enriched the arsenal of ammunition against human cancer Nevertheless, even though some of these drugs (i.e. the class of drugs named Immune-checkpoint-Inhibitors, ICi) have been sometimes hailed as “wonder drugs,” the … Continue reading Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow